The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
First-line doublet or triplet chemotherapy for advanced esophagogastric cancer: A systematic review and meta-analysis.
 
Nadia Haj Mohammad
No Relationships to Disclose
 
Emil ter Veer
No Relationships to Disclose
 
Lok Lam Ngai
No Relationships to Disclose
 
Rosa Mali
No Relationships to Disclose
 
Martijn G.H. van Oijen
Speakers' Bureau - Amgen; Bayer
Research Funding - Bayer; Lilly; Merck; Roche Pharma AG
 
Hanneke W.M. Van Laarhoven
Consulting or Advisory Role - Celgene; Gilead Sciences; Lilly; Nordic Group
Research Funding - Bayer Schering Pharma; Celgene; GlaxoSmithKline; Nordic Group; Roche Pharma AG